The Mizuho Trust & Banking Co. Ltd. Sells 5,402 Shares of Cigna Corp. (CI)

The Mizuho Trust & Banking Co. Ltd. Sells 5,402 Shares of Cigna Corp. (CI)

Mizuho Trust & Banking Co. Ltd. decreased its position in Cigna Corp. (NYSE:CI) by 1.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 453,458 shares of the company’s stock after selling 5,402 shares during the period. Mizuho Trust & Banking Co. Ltd. owned 0.18% of Cigna Corp. worth $59,095,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Acrospire Investment Management LLC raised its position in shares of Cigna Corp. by 166.7% in the second quarter. Acrospire Investment Management LLC now owns 800 shares of the company’s stock valued at $102,000 after buying an additional 500 shares during the last quarter. Invictus RG increased its position in shares of Cigna Corp. by 1,056.8% in the second quarter. Invictus RG now owns 1,018 shares of the company’s stock worth $130,000 after buying an additional 930 shares in the last quarter. First Financial Corp IN increased its position in shares of Cigna Corp. by 11.0% in the third quarter. First Financial Corp IN now owns 1,316 shares of the company’s stock worth $171,000 after buying an additional 130 shares in the last quarter. Johnson Financial Group Inc. increased its position in shares of Cigna Corp. by 996.9% in the second quarter. Johnson Financial Group Inc. now owns 1,426 shares of the company’s stock worth $183,000 after buying an additional 1,296 shares in the last quarter. Finally, Marco Investment Management LLC increased its position in shares of Cigna Corp. by 0.6% in the second quarter. Marco Investment Management LLC now owns 1,585 shares of the company’s stock worth $203,000 after buying an additional 10 shares in the last quarter. Hedge funds and other institutional investors own 84.56% of the company’s stock.

Cigna Corp. (NYSE:CI) opened at 141.97 on Thursday. The stock has a market cap of $36.45 billion, a P/E ratio of 19.29 and a beta of 0.54. Cigna Corp. has a 52 week low of $115.03 and a 52 week high of $148.99. The stock has a 50 day moving average price of $137.83 and a 200-day moving average price of $131.62.

Cigna Corp. (NYSE:CI) last announced its earnings results on Thursday, November 3rd. The company reported $1.94 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.91 by $0.03. Cigna Corp. had a net margin of 4.87% and a return on equity of 16.17%. The business earned $9.90 billion during the quarter, compared to the consensus estimate of $4.37 billion. During the same quarter last year, the firm earned $2.28 earnings per share. The business’s revenue for the quarter was up 5.2% on a year-over-year basis. On average, equities analysts anticipate that Cigna Corp. will post $7.99 EPS for the current fiscal year.

A number of brokerages have recently issued reports on CI. Zacks Investment Research raised Cigna Corp. from a “sell” rating to a “hold” rating in a research note on Tuesday, October 4th. Leerink Swann reaffirmed a “buy” rating and issued a $155.00 target price on shares of Cigna Corp. in a research report on Monday, September 26th. Piper Jaffray Cos. assumed coverage on Cigna Corp. in a research report on Wednesday, January 4th. They issued an “overweight” rating and a $170.00 target price for the company. Jefferies Group reaffirmed a “buy” rating and issued a $153.00 target price on shares of Cigna Corp. in a research report on Sunday, October 16th. Finally, Evercore ISI assumed coverage on Cigna Corp. in a research report on Thursday, September 22nd. They issued a “hold” rating and a $134.00 target price for the company. Five research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $158.08.

In other Cigna Corp. news, EVP John M. Murabito sold 58,822 shares of the firm’s stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $125.09, for a total transaction of $7,358,043.98. Following the completion of the transaction, the executive vice president now owns 115,109 shares of the company’s stock, valued at $14,398,984.81. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jason D. Sadler sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, October 31st. The shares were sold at an average price of $121.80, for a total transaction of $487,200.00. Following the transaction, the insider now directly owns 34,019 shares of the company’s stock, valued at approximately $4,143,514.20. The disclosure for this sale can be found here. Company insiders own 1.20% of the company’s stock.

Cigna Corp. Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp. (NYSE:CI).

Related posts

Leave a Comment